How Has the Vaccine Contract Manufacturing Market Evolved Historically and What is its Current Size?
The vaccine contract manufacturing market has seen considerable growth due to a variety of factors.
•In recent times, the vaccine contract manufacturing market has seen significant growth. The market is projected to expand from $3.58 billion in 2024 to $3.93 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 9.7%.
This growth during the historical period is due to several factors. These include constraints in traditional vaccine manufacturing, the increase in demand for vaccines caused by global disease outbreaks, regulatory backing for contract manufacturing, the rising complexity of vaccine production, and a spike in vaccine research and development.
What is the Forecasted Market Size and CAGR for the Vaccine Contract Manufacturing Market?
The vaccine contract manufacturing market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, the vaccine contract manufacturing market is set to experience a swift surge in its size. It's projected to expand to $5.93 billion in 2029 with a compound annual growth rate of 10.8%.
This upswing in the forecast period can be credited to factors such as heightened focus on readiness for pandemics, an uptick in pharmaceutical manufacturing outsourcing, burgeoning biopharmaceutical firms, hastened vaccine development schedules, and worldwide efforts to enhance vaccine availability. The forecast period is expected to see key trends like the integration of disposable technologies in production, elevated utilization of personalized medicine methods in vaccine creation, advancements in mRNA and viral vector vaccines, implementation of continuous production processes, and broadening of fill-finish services.
What Are The Key Drivers Fueling Growth In The Vaccine Contract Manufacturing Market?
Growth in the vaccine contract manufacturing market is expected to be driven by an uptick in initiatives that promote vaccinations. Vaccinations are a simple, safe, and effective strategy to prevent widespread diseases, stimulating the immune system and enhancing the body's resistance to infections. The growth and evolution of various vaccine manufacturing techniques will be facilitated by these vaccination initiatives, benefitting contract manufacturing in the vaccine sector. For example, in November 2022, the U.S. Department of Health and Human Services, an executive department of the US federal government, launched a $350 million initiative for HRSA-supported health establishments to amplify the distribution of COVID-19 vaccines in their communities, particularly for marginalized populations. Consequently, initiatives that support vaccinations are catalyzing the expansion of the vaccine contract manufacturing market.
What Are The Principal Market Segments In The Global Vaccine Contract Manufacturing Industry?
The vaccine contract manufacturing market covered in this report is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary
Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling
2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation
Pre-Book The Vaccine Contract Manufacturing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Vaccine Contract Manufacturing Sector?
One significant trend gaining traction in the vaccine contract manufacturing market is strategic collaborations. Many major firms are forming alliances with companies in the vaccine contract manufacturing sector to maintain their market standing. For instance, Vaxxas, a biotechnology firm from Australia known for its innovative needle-free vaccination tech, joined forces with the Coalition for Epidemic Preparedness Innovations, a foundation based in Norway, in January 2023. The union aimed to financially support and guide the creation of new vaccines and further the development of Vaxxas' needle-free vaccine patch delivery technology, which could eliminate the need for frozen storage of mRNA vaccines. In another example, LenioBio, a German Biotech firm, formed a partnership with ReciBioPharm, a US-based contract development and manufacturing organization (CDMO), in October 2024. This collaboration aimed to augment LenioBio’s protein production capabilities and hasten vaccine production. It aligns with LenioBio's plan to broaden its CEPI-funded project's scope, aiming to exhibit the speed and effectiveness of its proprietary ALiCE protein expression technology in generating vaccine-related proteins intended for clinical trial usage.
Who Are the Key Players in the Vaccine Contract Manufacturing Market?
Major companies operating in the vaccine contract manufacturing market include:
• Pfizer Inc
• Johnson & Johnson
• AbbVie Inc.
• Sanofi
• GlaxoSmithKline
• Merck KGaA
• Fujifilm Holdings Corporation
• Moderna
• BioNTech
• GSK Vaccines
• AstraZeneca PLC
• Ajinomoto Co. Inc.
• Icon plc
• Lonza Group AG
• Cytiva
• Catalent Inc.
• Charles River Laboratories International Inc.
• Serum Institute of India Pvt. Ltd
• Samsung Biologics
• WuXi Biologics
• Novavax
• Sinovac Biotech
• Emergent BioSolutions Inc.
• Albany Molecular Research Inc.
• Soligenix Inc.
• Bio Farma
• Curia Global Inc.
• Hualan Biological Engineering
• BioMARC
• Bavarian Nordic A/S
• AGC Biologics
• IDT Biologika GmbH
• Bharat Biotech
• Goodwin Biotechnology Inc.
• Biofabri S.L
What are the Regional Insights into the Vaccine Contract Manufacturing Market?
North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
